QBIO (Q BioMed) EPS (Diluted): $-0.08 (TTM As of Feb. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Q BioMed EPS (Diluted)?

Q BioMed QBIO -99.00% EPS (Diluted) is $-0.08 as of Feb. 2023.

Q BioMed's Earnings per Share (Diluted) for the three months ended in Feb. 2023 was $-0.02. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2023 was $-0.08.

Q BioMed's EPS (Basic) for the three months ended in Feb. 2023 was $-0.02. Its EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2023 was $-0.08.

Q BioMed's EPS without NRI for the three months ended in Feb. 2023 was $-0.02. Its EPS without NRI for the trailing twelve months (TTM) ended in Feb. 2023 was $-0.09.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Q BioMed  (OTCPK:QBIO) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Q BioMed EPS (Diluted) Related Terms

Q BioMed EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for Q BioMed's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q BioMed EPS (Diluted) Chart

Q BioMed Annual Data
Trend Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.67 -0.68 -0.65 -0.33 -0.08

Q BioMed Quarterly Data
May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 -0.06 -0.03 0.03 -0.02

QBIO vs RGMP, CALA, PPCB: EPS (Diluted) Comparison

For the Biotechnology subindustry, Q BioMed's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Q BioMed PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q BioMed's PE Ratio distribution charts can be found below:

* The bar in red indicates where Q BioMed's PE Ratio falls into.


Q BioMed EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Q BioMed's Diluted EPS for the fiscal year that ended in Nov. 2022 is calculated as

Diluted EPS (A: Nov. 2022 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-2.052-1.442)/44.757
=-0.08

Q BioMed's Diluted EPS for the quarter that ended in Feb. 2023 is calculated as

Diluted EPS (Q: Feb. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.722-0.105)/108.730
=-0.01

EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of $-0.08 mean?
Q BioMed (QBIO) has a EPS (Diluted) of $-0.08 as of Feb. 2023. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Q BioMed and its competitors.
Is Q BioMed's EPS (Diluted) too high?
Q BioMed's current EPS (Diluted) is $-0.08.
How does Q BioMed's EPS (Diluted) compare to RGMP and CALA?
Q BioMed's EPS (Diluted) of $-0.08 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Biotechnology company?
A good EPS (Diluted) depends on the Biotechnology industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Q BioMed and its competitors. Q BioMed's current EPS (Diluted) is $-0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q BioMed stock overvalued right now?
Q BioMed (QBIO) has a current EPS (Diluted) of $-0.08. The current EPS (Diluted) is $-0.08. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Q BioMed (QBIO), the current EPS (Diluted) is $-0.08 as of Feb. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q BioMed Business Description

Address c/o Ortoli Rosenstadt LLP, 366 Madison Avenue, 3rd Floor, New York, NY, USA, 10017
Q BioMed Inc is a biotech acceleration and commercial stage company. It is focused on licensing and acquiring undervalued biomedical assets in the healthcare sector. The company provides these target assets the strategic resources, developmental support, and expansion capital needed to ensure customers meet their developmental potential, enabling them to provide products to patients in need.